This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Company Profile For Alere Analytics

Alere Analytics, formerly DiagnosisOne, provides the healthcare industry with unparalleled analytics and clinical decision support tools based on a single platform. The Company leverages the world's largest library of evidence-based medical knowledge and integrates seamlessly with existing hospital and laboratory information systems. It delivers intelligent and actionable information that ensures improved patient care, fewer errors and better clinical outcomes. Our solutions are built on the most up-to-date methods of data interoperability including HL7 v3.0/2.X, CCD and CDA standards. Alere Analytics’ customers include hospitals, healthcare providers, payers, EHR companies, systems integrators and government entities. Based in Lowell, Mass., Alere Analytics was formed as DiagnosisOne in 2003 by a team of physicians and healthcare IT professionals. In July 2012, DiagnosisOne joined Alere, a leading provider of near-patient diagnostics and health information solutions, and is now conducting business as Alere Analytics. For more information about the Company and its solutions, visit www.alereanalytics.com.

Company:

  Alere Analytics
 

Headquarters Address:

900 Chelmsford Street

Tower 3, 7th Floor
Lowell, MA 01851
 

Main Telephone:

9788564600
 

Website:

www.alereanalytics.com

 

Ticker:

ALR(NYSE)
 

Type of Organization:

Public
 

Industry:

Software
 

Key Executives:

CEO: Mansoor Khan

CMO: Fauzia Khan

 

Public Relations

 

Contact:

Lisa Rivero

Phone:

9788564524

Email:

lisa.rivero@alere.com





Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs